Literature DB >> 17603158

Alpha1-acid glycoprotein suppresses rat acute inflammatory paw edema through the inhibition of neutrophils activation and prostaglandin E2 generation.

Kazuaki Matsumoto1, Koji Nishi, Mari Kikuchi, Daisuke Kadowaki, Yoshiko Tokutomi, Naofumi Tokutomi, Katsuhide Nishi, Ayaka Suenaga, Masaki Otagiri.   

Abstract

Alpha(1)-acid glycoprotein (AGP) is an acute phase protein. Whereas the expression of AGP in an inflammatory state is enhanced by inflammatory cytokines including interleukin-1, 6 (IL-1 and IL-6), and tumor necrosis factor-alpha (TNF-alpha), the biological significance of AGP remains unclear. In the current study, the anti-inflammatory effect of AGP on the acute inflammatory state was examined in vivo and in vitro. AGP suppressed carrageenan-, dextran- and kaolin-induced paw edema and vascular permeability in rat. These results suggest that both initial inflammatory mediators (serotonin and histamine) and later inflammatory mediators (prostaglandin and bradykinin) are involved in the anti-inflammatory effects of AGP. In fact, prostaglandin E(2) (PGE(2)) generation in plasma was significantly inhibited by AGP. Moreover, AGP inhibited the migration of neutrophils treated with N-formyl-methionyl-leucyl-phenylalanine (fMLP) through membrane filter. In addition, AGP significantly suppressed superoxide generation from neutrophils that has been treated with fMLP or phorbol 12-myristate 13-acetate. These results imply that the anti-inflammatory effect of AGP may involve the inhibition of neutrophils migration. The data obtained in this study support a scenario in which an increase in AGP concentration in pathological conditions suppresses inflammation reactions induced by autacoids and neutrophils activities and that AGP plays an important role in the maintenance in the body.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603158     DOI: 10.1248/bpb.30.1226

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  Active and Passive Immunization Against Staphylococcus aureus Periprosthetic Osteomyelitis in Rats.

Authors:  Niels H Søe; Nina Vendel Jensen; Asger Lundorff Jensen; Janne Koch; Steen Seier Poulsen; Gerald B Pier; Helle Krogh Johansen
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

2.  α1-Acid glycoprotein induced effects in rat brain microvessel endothelial cells.

Authors:  Shuangling Zhang; Karen S Mark
Journal:  Microvasc Res       Date:  2012-05-25       Impact factor: 3.514

3.  Intra-articular versus systemic vancomycin for the treatment of periprosthetic joint infection after debridement and spacer implantation in a rat model.

Authors:  Jian Wei; Kai Tong; Hui Wang; Yinxian Wen; Liaobin Chen
Journal:  Bone Joint Res       Date:  2022-06       Impact factor: 4.410

4.  Adhesion of malignant mammary tumor cells MDA-MB-231 to microvessel wall increases microvascular permeability via degradation of endothelial surface glycocalyx.

Authors:  Bin Cai; Jie Fan; Min Zeng; Lin Zhang; Bingmei M Fu
Journal:  J Appl Physiol (1985)       Date:  2012-08-02

5.  Local Application of Vancomycin in One-Stage Revision of Prosthetic Joint Infection Caused by Methicillin-Resistant Staphylococcus aureus.

Authors:  Jian Wei; Yinxian Wen; Kai Tong; Hui Wang; Liaobin Chen
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

6.  A novel knee prosthesis model of implant-related osteomyelitis in rats.

Authors:  Niels H Søe; Nina Vendel Jensen; Birgit Meinecke Nürnberg; Asger Lundorff Jensen; Janne Koch; Steen Seier Poulsen; Gerald Pier; Helle Krogh Johansen
Journal:  Acta Orthop       Date:  2013-02       Impact factor: 3.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.